New Lymphoma Treatment Gets 97% Success Rate

Patients with early-stage Hodgkin lymphoma are achieving a 97% cancer-free rate after two years using a new treatment combination that requires less chemotherapy than traditional approaches. The breakthrough offers hope for thousands facing this diagnosis each year.